Search

everythinglearnresearchcommunity

for

Search:↓

Activating cannabinoid receptor 1 may help manage psoriasis by reducing certain keratins.

Blocking LFA-1 prevents hair loss in mice.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Access to JAK inhibitors for alopecia areata should be improved in the Military Healthcare System.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

Blocking JAK-STAT5 signaling in mice leads to hair growth.

Blocking YAP/TAZ could be a new way to treat skin cancer.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

JAK inhibitors show promise for treating Alopecia Areata, but more research is needed for better, accessible treatments.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.